NRD
MD icon

Nebula Research & Development’s Pediatrix Medical MD Stock Holding History

Nebula Research & Development’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,540
Closed -$79.6K – 1083
2024
Q2 		$79.6K Buy
+10,540
New +$87.2K 0.01% 776
2024
Q1 		– Sell
-20,898
Closed -$194K – 887
2023
Q4 		$194K Buy
+20,898
New +$216K 0.06% 554

Other funds holding MD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Nebula Research & Development's MD Position: Q3 2024 in Review

Nebula Research & Development sold out of Pediatrix Medical (MD) in Q3 2024, closing a stake of 10,540 shares — an estimated $79.6K sold.

Nebula Research & Development first reported a position in MD in Q4 2023 and held it in 2 quarters. The position peaked at $194K in Q4 2023. 218 funds tracked by Wall St. Rank hold MD as of Q3 2024.

  • Nebula Research & Development reported no remaining Pediatrix Medical position as of Q3 2024 after selling out during the quarter.
  • Nebula Research & Development sold 10,540 Pediatrix Medical shares in Q3 2024, an estimated $79.6K.
  • Nebula Research & Development first reported a position in Pediatrix Medical in Q4 2023 and held it in 2 quarters.
  • Nebula Research & Development's Pediatrix Medical position peaked at $194K in Q4 2023.
  • 218 funds tracked by Wall St. Rank held Pediatrix Medical as of Q3 2024.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.